8 Knots Management LLC Cuts Stock Holdings in Alignment Healthcare, Inc. $ALHC

8 Knots Management LLC lowered its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 35.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,868,367 shares of the company’s stock after selling 1,024,726 shares during the period. Alignment Healthcare makes up 4.3% of 8 Knots Management LLC’s holdings, making the stock its 7th largest position. 8 Knots Management LLC’s holdings in Alignment Healthcare were worth $36,900,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of ALHC. Parallel Advisors LLC boosted its stake in Alignment Healthcare by 87.7% during the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after buying an additional 773 shares in the last quarter. Larson Financial Group LLC bought a new position in Alignment Healthcare during the third quarter valued at about $33,000. First Horizon Corp bought a new position in Alignment Healthcare during the fourth quarter valued at about $39,000. GAMMA Investing LLC grew its holdings in shares of Alignment Healthcare by 83.8% in the 4th quarter. GAMMA Investing LLC now owns 2,165 shares of the company’s stock worth $43,000 after acquiring an additional 987 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in shares of Alignment Healthcare in the 3rd quarter worth $53,000. Institutional investors own 86.19% of the company’s stock.

Insider Activity

In related news, President Dawn Christine Maroney sold 36,749 shares of the business’s stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total transaction of $655,602.16. Following the completion of the transaction, the president owned 1,058,813 shares of the company’s stock, valued at approximately $18,889,223.92. The trade was a 3.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO John E. Kao sold 298,000 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $16.89, for a total value of $5,033,220.00. Following the transaction, the chief executive officer owned 1,508,641 shares in the company, valued at $25,480,946.49. This represents a 16.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,584,685 shares of company stock valued at $30,401,143 in the last three months. 5.20% of the stock is owned by insiders.

Alignment Healthcare Price Performance

ALHC opened at $19.75 on Friday. The stock has a market cap of $4.08 billion, a price-to-earnings ratio of 219.44, a PEG ratio of 2.67 and a beta of 1.14. Alignment Healthcare, Inc. has a 1 year low of $11.63 and a 1 year high of $23.87. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The stock has a fifty day moving average price of $18.53 and a 200 day moving average price of $19.40.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.04. Alignment Healthcare had a return on equity of 11.50% and a net margin of 0.47%.The company had revenue of $1.24 billion during the quarter, compared to analysts’ expectations of $1.22 billion. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. The business’s quarterly revenue was up 33.3% compared to the same quarter last year. Analysts forecast that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ALHC. Wolfe Research began coverage on Alignment Healthcare in a report on Friday, April 17th. They issued an “outperform” rating and a $24.00 target price on the stock. Raymond James Financial set a $22.00 target price on Alignment Healthcare in a report on Thursday, May 7th. Weiss Ratings upgraded Alignment Healthcare from a “sell (d-)” rating to a “hold (c-)” rating in a report on Thursday, May 7th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Alignment Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $24.30.

About Alignment Healthcare

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.